A6X-15419-36736
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2020-12-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-14
Registered in v-safe
-
2020-12-14
Dose 1 — Pfizer-BioNTech
- 2020-12-14
- 2020-12-15
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-28
-
2021-01-04
Dose 2 — Pfizer-BioNTech
- 2021-01-04
- 2021-01-06
- 2021-01-08
- 2021-01-10
- 2021-01-11
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
-
2021-04-05
Survey response — 3 months, dose 2MedDRA: Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Sore throat, cough, congestion, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-05
-
2021-09-14
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-12-14
- 2022-03-17
- 2022-09-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-14 | Pfizer-BioNTech | |
| 2 | 2021-01-04 | Pfizer-BioNTech | |
| 3 | 2021-09-14 | Pfizer-BioNTech | No |
Free text
Release 6 — 3 months, dose 2
Symptoms: Sore throat, cough, congestion, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release